PAVANELLO, CHIARA
PAVANELLO, CHIARA
Dipartimento di Scienze Farmacologiche e Biomolecolari
A proteomic approach to identify novel disease biomarkers in LCAT deficiency
2018 S. Simonelli, A. Ossoli, C. Banfi, C. Pavanello, L. Calabresi, E. Gianazza
Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency
2023 M. Gomaraschi, M. Turri, A. Strazzella, M. Lhomme, C. Pavanello, W. Le Goff, A. Kontush, L. Calabresi, A. Ossoli
Activation of naturally occurring LCAT mutants by a novel activator compound
2020 C. Pavanello, A. Ossoli, M. Turri, A. Strazzella, S. Simonelli, T. Laurenzi, K. Kono, K. Yamada, N. Kiyosawa, I. Eberini, L. Calabresi
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation
2019 R. Scicali, A. Di Pino, C. Pavanello, A. Ossoli, A. Strazzella, A. Alberti, S. Di Mauro, A. Scamporrino, F. Urbano, A. Filippello, S. Piro, A.M. Rabuazzo, L. Calabresi, F. Purrello
Apolipoprotein E isoforms differentially affect LCAT-dependent cholesterol esterification
2023 C. Vitali, C. Pavanello, M. Turri, S. Lund-Katz, M.C. Phillips, A.L. Catapano, A. Baragetti, G.D. Norata, F. Veglia, L. Calabresi
Appropriateness of statin prescription in the elderly
2018 M. Ruscica, C. Macchi, C. Pavanello, A. Corsini, A. Sahebkar, C.R. Sirtori
Autosomal recessive hypercholesterolemia : long-term cardiovascular outcomes
2018 L. D'Erasmo, I. Minicocci, A. Nicolucci, P. Pintus, J.E. Roeters Van Lennep, L. Masana, P. Mata, R.M. Sánchez-Hernández, P. Prieto-Matos, J.T. Real, J.F. Ascaso, E.E. Lafuente, M. Pocovi, F.J. Fuentes, S. Muntoni, S. Bertolini, C. Sirtori, L. Calabresi, C. Pavanello, M. Averna, A.B. Cefalu, D. Noto, A.A. Pacifico, G.M. Pes, M. Harada-Shiba, E. Manzato, S. Zambon, A. Zambon, A. Vogt, M. Scardapane, B. Sjouke, R. Fellin, M. Arca
CA-IMT and QT parameters in dyslipidemic patients in primary prevention at different ESC/EAS cardiovascular risk levels
2013 G. Mombelli, B. Terraneo, F. Pazzucconi, C. Pavanello, R. Bosisio, M. Triolo, V. Barbieri, P. Magni, S. Castelnuovo, C.R. Sirtori, L. Calabresi
Cardiovascular determinants of QT interval duration in dysplipidemic patients in primary prevention in two genders
2013 G. Mombelli, B. Terraneo, F. Pazzucconi, C. Pavanello, M. Triolo, V. Barbieri, S. Castelnuovo, C.R. Sirtori
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis
2022 R. Colantuono, C. Pavanello, A. Pietrobattista, M. Turri, P. Francalanci, M. Spada, P. Vajro, L. Calabresi, C. Mandato
Considering gender in prescribing statins : what do physicians need to know?
2015 C. Pavanello, G. Mombelli
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency
2017 M. Gomaraschi, A. Ossoli, S. Castelnuovo, S. Simonelli, C. Pavanello, G. Balzarotti, M. Arca, A. Di Costanzo, T. Sampietro, G. Vaudo, D. Baldassarre, F. Veglia, G. Franceschini, L. Calabresi
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency
2017 M. Gomaraschi, A. Ossoli, S. Castelnuovo, S. Simonelli, C. Pavenello, G. Balzarotti, M. Arca, A. Di Costanzo, T. Sampietro, G. Vaudo, D. Baldassarre, F. Veglia, G. Franceschini, L. Calabresi
Dysfunctional HDL as a therapeutic target for atherosclerosis prevention
2019 A. Ossoli, C. Pavanello, E. Giorgio, L. Calabresi, M. Gomaraschi
Effect of soy on metabolic syndrome and cardiovascular risk factors : a randomized controlled trial
2018 M. Ruscica, C. Pavanello, S. Gandini, M. Gomaraschi, C. Vitali, C. Macchi, B. Morlotti, G. Aiello, R. Bosisio, L. Calabresi, A. Arnoldi, C.R. Sirtori, P. Magni
Effects of a lupin protein concentrate on lipids, blood pressure and insulin resistance in moderately dyslipidaemic patients : a randomised controlled trial
2017 C. Pavanello, C. Lammi, M. Ruscica, R. Bosisio, G. Mombelli, C. Zanoni, L. Calabresi, C.R. Sirtori, P. Magni, A. Arnoldi
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation
2022 M. Palumbo, A. Giammanco, F. Purrello, C. Pavanello, G. Mombelli, A. Di Pino, S. Piro, A.B. Cefalù, L. Calabresi, M. Averna, F. Bernini, F. Zimetti, M.P. Adorni, R. Scicali
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study
2022 D. Laura, S. Kim, C. Angelo Baldassare, D.C. Alessia, B. Eric, B. Simone, A. Marcello, V.L. Jeanine Roeters, A. Giammanco, M. Averna, G. Iannuzzo, G. Fortunato, M. Gentile, A. Puja, T. Montalcini, C. Pavanello, L. Calabresi, G. Battista Vigna, M. Bucci, K. Bonomo, F. Nota, T. Sampietro, F. Sbrana, P. Suppressa, C. Sabbà, F. Fimiani, A. Cesaro, P. Calabrò, F. Ventura, S. D'Addato, L. Pisciotta, S. Bertolini, M. Arca, G. Kolovou, E. Liberopoulos, E. Daphnis, J. Roeters van Lennep, J. Rutten, E. Boersma, K. Steward, A. Vogt, J. Cegla, S. Walji, M. Kayikcioglu, J. Real, S. Martínez-Hervás, A. Ellis, K. Littmann
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open label interventional study
2023 A. Ehrlich, K. Ioannidis, M. Nasar, I. Abu Alkian, Y. Daskal, N. Atari, L. Kliker, N. Rainy, M. Hofree, S. Shafran Tikva, I. Houri, A. Cicero, C. Pavanello, C.R. Sirtori, J.B. Cohen, J.A. Chirinos, L. Deutsch, M. Cohen, A. Gottlieb, A. Bar-Chaim, O. Shibolet, M. Mandelboim, S. Maayan, Y. Nahmias
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia : Results of a Real-World Clinical Experience in Italy
2017 L. D’Erasmo, A. Baldassare Cefalù, D. Noto, A. Giammanco, M. Averna, P. Pintus, P. Medde, G.B. Vigna, C. Sirtori, L. Calabresi, C. Pavanello, M. Bucci, C. Sabbà, P. Suppressa, F. Natale